
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| MB_ML_L | 420 | 31.7% | 0.93 | 800 | 34.9% |
| CRE_L | 339 | 25.5% | 1.19 | 775 | 33.8% |
| MB_PED_L | 277 | 20.9% | 0.82 | 488 | 21.3% |
| MB_CA_L | 160 | 12.1% | -2.42 | 30 | 1.3% |
| SMP_L | 61 | 4.6% | 0.91 | 115 | 5.0% |
| PLP_L | 23 | 1.7% | 1.72 | 76 | 3.3% |
| SCL_L | 22 | 1.7% | -2.46 | 4 | 0.2% |
| SLP_L | 17 | 1.3% | -3.09 | 2 | 0.1% |
| LH_L | 8 | 0.6% | -2.00 | 2 | 0.1% |
| MB_VL_L | 0 | 0.0% | inf | 1 | 0.0% |
| upstream partner | # | NT | conns KCg-s2 | % In | CV |
|---|---|---|---|---|---|
| KCg-d (L) | 121 | ACh | 344 | 28.1% | 0.7 |
| KCg-m (L) | 204 | ACh | 314 | 25.7% | 2.1 |
| KCg-s2 (L) | 1 | ACh | 100 | 8.2% | 0.0 |
| VP3+_vPN (L) | 1 | GABA | 44 | 3.6% | 0.0 |
| KCg-s3 (L) | 1 | ACh | 36 | 2.9% | 0.0 |
| PAM08 (L) | 11 | DA | 34 | 2.8% | 0.7 |
| SLP184 (L) | 1 | ACh | 32 | 2.6% | 0.0 |
| PPL103 (L) | 1 | DA | 30 | 2.5% | 0.0 |
| APL (L) | 1 | GABA | 29 | 2.4% | 0.0 |
| VP2_adPN (L) | 1 | ACh | 22 | 1.8% | 0.0 |
| KCg-s1 (L) | 1 | ACh | 21 | 1.7% | 0.0 |
| DPM (L) | 1 | DA | 19 | 1.6% | 0.0 |
| PPL101 (R) | 1 | DA | 15 | 1.2% | 0.0 |
| CB1321 (L) | 3 | ACh | 14 | 1.1% | 0.5 |
| PPL101 (L) | 1 | DA | 13 | 1.1% | 0.0 |
| KCapbp-ap1 (L) | 11 | ACh | 12 | 1.0% | 0.3 |
| PPL103 (R) | 1 | DA | 11 | 0.9% | 0.0 |
| PAM08 (R) | 5 | DA | 11 | 0.9% | 0.5 |
| MBON09 (L) | 2 | GABA | 10 | 0.8% | 0.2 |
| CB4219 (L) | 2 | ACh | 10 | 0.8% | 0.2 |
| PAM07 (L) | 4 | DA | 7 | 0.6% | 0.7 |
| aMe26 (R) | 3 | ACh | 7 | 0.6% | 0.4 |
| M_l2PNm16 (L) | 1 | ACh | 5 | 0.4% | 0.0 |
| PPL102 (R) | 1 | DA | 5 | 0.4% | 0.0 |
| MBON05 (R) | 1 | Glu | 5 | 0.4% | 0.0 |
| OA-VPM4 (R) | 1 | OA | 4 | 0.3% | 0.0 |
| DN1-l (L) | 1 | Glu | 4 | 0.3% | 0.0 |
| aMe26 (L) | 3 | ACh | 4 | 0.3% | 0.4 |
| CB3206 (L) | 1 | ACh | 3 | 0.2% | 0.0 |
| MBON11 (L) | 1 | GABA | 3 | 0.2% | 0.0 |
| PAM12 (L) | 2 | DA | 3 | 0.2% | 0.3 |
| VP1m+_lvPN (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 2 | 0.2% | 0.0 |
| LHPV12a1 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| SMP142,SMP145 (L) | 1 | DA | 2 | 0.2% | 0.0 |
| PAM02 (L) | 1 | DA | 2 | 0.2% | 0.0 |
| MBON04 (R) | 1 | Glu | 2 | 0.2% | 0.0 |
| DN1a (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| AVLP562 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| CB3709 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| PAM12 (R) | 2 | DA | 2 | 0.2% | 0.0 |
| M_lPNm11A (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| PAM05 (L) | 2 | DA | 2 | 0.2% | 0.0 |
| PAM07 (R) | 2 | DA | 2 | 0.2% | 0.0 |
| PFR (R) | 2 | Unk | 2 | 0.2% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 1 | 0.1% | 0.0 |
| FR1 (R) | 1 | Unk | 1 | 0.1% | 0.0 |
| DNp62 (L) | 1 | 5-HT | 1 | 0.1% | 0.0 |
| DNp30 (R) | 1 | 5-HT | 1 | 0.1% | 0.0 |
| CRE102 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB0951 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| ALIN1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PPL202 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| M_lPNm11B (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| KCab-p (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MBON01 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| mALD2 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| PPL201 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| TuBu09,TuBu10 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| DP1m_adPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PPL203 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| MBON22 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE107 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| VL1_ilPN (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| M_lPNm11D (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPD2c7 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| KCapbp-ap2 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LAL185 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE042 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns KCg-s2 | % Out | CV |
|---|---|---|---|---|---|
| KCg-m (L) | 227 | ACh | 358 | 21.7% | 1.9 |
| KCg-d (L) | 108 | ACh | 313 | 19.0% | 0.8 |
| MBON05 (R) | 1 | Glu | 125 | 7.6% | 0.0 |
| KCg-s2 (L) | 1 | ACh | 100 | 6.1% | 0.0 |
| PAM08 (L) | 21 | DA | 92 | 5.6% | 0.8 |
| MBON09 (L) | 2 | GABA | 72 | 4.4% | 0.1 |
| APL (L) | 1 | GABA | 68 | 4.1% | 0.0 |
| KCg-s3 (L) | 1 | ACh | 39 | 2.4% | 0.0 |
| DPM (L) | 1 | DA | 34 | 2.1% | 0.0 |
| PAM07 (L) | 8 | DA | 31 | 1.9% | 0.3 |
| MBON33 (L) | 1 | ACh | 30 | 1.8% | 0.0 |
| MBON11 (L) | 1 | GABA | 26 | 1.6% | 0.0 |
| PAM08 (R) | 14 | DA | 21 | 1.3% | 0.4 |
| MBON04 (R) | 1 | Glu | 19 | 1.2% | 0.0 |
| MBON21 (L) | 1 | ACh | 19 | 1.2% | 0.0 |
| MBON32 (L) | 1 | GABA | 18 | 1.1% | 0.0 |
| PPL101 (L) | 1 | DA | 16 | 1.0% | 0.0 |
| PPL101 (R) | 1 | DA | 15 | 0.9% | 0.0 |
| TuBu08 (L) | 4 | ACh | 15 | 0.9% | 0.5 |
| MBON22 (L) | 1 | ACh | 13 | 0.8% | 0.0 |
| PPL103 (L) | 1 | DA | 11 | 0.7% | 0.0 |
| MBON29 (L) | 1 | ACh | 11 | 0.7% | 0.0 |
| PAM12 (L) | 5 | DA | 11 | 0.7% | 0.7 |
| TuBu09,TuBu10 (L) | 7 | ACh | 11 | 0.7% | 0.6 |
| PAM07 (R) | 6 | DA | 11 | 0.7% | 0.4 |
| KCg-s1 (L) | 1 | ACh | 10 | 0.6% | 0.0 |
| PPL102 (R) | 1 | DA | 10 | 0.6% | 0.0 |
| LHPV3c1 (L) | 1 | ACh | 9 | 0.5% | 0.0 |
| PPL103 (R) | 1 | DA | 9 | 0.5% | 0.0 |
| PAM05 (L) | 2 | DA | 9 | 0.5% | 0.6 |
| MBON35 (L) | 1 | ACh | 8 | 0.5% | 0.0 |
| MBON27 (L) | 1 | ACh | 7 | 0.4% | 0.0 |
| PAM12 (R) | 3 | DA | 7 | 0.4% | 0.8 |
| KCapbp-ap1 (L) | 7 | ACh | 7 | 0.4% | 0.0 |
| MBON12 (L) | 1 | ACh | 6 | 0.4% | 0.0 |
| MBON26 (L) | 1 | ACh | 6 | 0.4% | 0.0 |
| MBON01 (R) | 1 | Glu | 6 | 0.4% | 0.0 |
| PAM02 (L) | 3 | DA | 5 | 0.3% | 0.3 |
| PAM01 (R) | 3 | DA | 5 | 0.3% | 0.3 |
| CRE024 (R) | 1 | ACh | 4 | 0.2% | 0.0 |
| DNp30 (R) | 1 | 5-HT | 4 | 0.2% | 0.0 |
| CRE048 (L) | 1 | Glu | 3 | 0.2% | 0.0 |
| CRE072 (L) | 2 | ACh | 3 | 0.2% | 0.3 |
| OA-VPM4 (R) | 1 | OA | 2 | 0.1% | 0.0 |
| LAL155 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| LAL002 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| LHCENT3 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| SMP238 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| mALD3 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| CB0951 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE011 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB0546 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL129 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| M_lPNm11B (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe12 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| VP3+_vPN (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CB1947 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV2a1_a (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LHCENT11 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB2781 (L) | 1 | Unk | 1 | 0.1% | 0.0 |
| KCapbp-m (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB1784 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MBON30 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| DN1a (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PFR (R) | 1 | Unk | 1 | 0.1% | 0.0 |
| CRE022 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE107 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| SMP049,SMP076 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| AVLP563 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| FR1 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| PLP042b (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LAL185 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| VA3_adPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB1454 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| AL-MBDL1 (L) | 1 | Unk | 1 | 0.1% | 0.0 |
| PAM13 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| aMe12 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MBON30 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE001 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| KCab (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP144 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CRE060,CRE067 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| PAM06 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| AOTU019 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CRE105 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe26 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB1287 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB3206 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PAM01 (L) | 1 | DA | 1 | 0.1% | 0.0 |